<DOC>
	<DOCNO>NCT01558778</DOCNO>
	<brief_summary>This pilot clinical trial study mechanical stimulation prevent bone density loss patient undergo donor stem cell transplant . Mechanical stimulation may limit , prevent , reverse bone loss , increase muscle cardiac performance , improve overall health</brief_summary>
	<brief_title>Mechanical Stimulation Preventing Bone Density Loss Patients Undergoing Donor Stem Cell Transplant</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine feasibility mechanical stimulation regimen hematopoietic cell transplant ( HCT ) patient . SECONDARY OBJECTIVES : I . To evaluate data collection tool prepare large phase II trial . OUTLINE : Patients undergo mechanical stimulation 20 minute daily ( QD ) begin date hospital admission continue day 100 post-HCT , except day 0 ( date transplant ) .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Burkitt Lymphoma</mesh_term>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Lymphoma , Large-Cell , Immunoblastic</mesh_term>
	<mesh_term>Plasmablastic Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Mantle-Cell</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Lymphoma , B-Cell , Marginal Zone</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Mycosis Fungoides</mesh_term>
	<mesh_term>Primary Myelofibrosis</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Sezary Syndrome</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Germinoma</mesh_term>
	<mesh_term>Leukemia , Hairy Cell</mesh_term>
	<mesh_term>Myeloproliferative Disorders</mesh_term>
	<mesh_term>Leukemia , Myeloid , Chronic-Phase</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Chronic</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Myelodysplastic-Myeloproliferative Diseases</mesh_term>
	<mesh_term>Leukemia , Prolymphocytic</mesh_term>
	<mesh_term>Leukemia , Myeloid , Chronic , Atypical , BCR-ABL Negative</mesh_term>
	<mesh_term>Hypereosinophilic Syndrome</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Plasmacytoma</mesh_term>
	<mesh_term>Blast Crisis</mesh_term>
	<mesh_term>Leukemia , Myeloid , Accelerated Phase</mesh_term>
	<mesh_term>Leukemia , Neutrophilic , Chronic</mesh_term>
	<mesh_term>Trophoblastic Neoplasms</mesh_term>
	<mesh_term>Gestational Trophoblastic Disease</mesh_term>
	<criteria>Meet eligibility criterion first allogeneic HCT , schedule undergo allogeneic HCT Pretransplant Karnofsky Performance Status ( KPS ) &gt; = 70 Patient legal representative must understand investigational nature study sign Institutional Review Board approve write informed consent form prior receive study related procedure Any prior allogeneic HCT Pretransplant weight &gt; = 280 lb Body mass index ( BMI ) &lt; l8kg/m^2 Human leukocyte antigen ( HLA ) mismatch HCT Cord blood transplant Osteopenia osteoporosis ( Tscore = &lt; 1.0 ) Multiple myeloma diagnosis Any prior history central nervous system ( CNS ) hemorrhage Currently treat therapeutic dose anticoagulation recent pulmonary embolism deep vein thrombosis Current previous bisphosphonate use Prior history nontraumatic fracture Any screw , pin , rod , metal object body Total joint replacement History kidney stone gall stone Any artificial limb Pregnant nursing female patient Unwilling unable follow protocol requirement Any condition Investigator 's opinion deem patient unsuitable candidate receive study intervention</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>